Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT01147003
Brief Summary:
This study will assess the efficacy and safety of BGG492 as adjunctive treatment in patients with partial onset seizures.
Study:
NCT01147003
Study Brief:
Protocol Section:
NCT01147003